Compare ProShares Ultra QQQ ETF (QLD) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra QQQ ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? ProShares Ultra QQQ ETF trades at $98.49 (market cap $15.38B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while ProShares Ultra QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold ProShares Ultra QQQ ETF for 36 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| QLD | RPRX | |
|---|---|---|
Market Cap | $15.38B | $25.27B |
Volume | 4,844,085 | 3,671,183 |
Sector | Leveraged / Inverse | Health |
52-Week High | $100.77 | $63.96 |
52-Week Low | $57.16 | $35.44 |
Typical Hold Time | 36 Days | 1 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QLD trades at $98.43, down 1.8% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF maintains key support at $96 with resistance at $100. Recent news highlights QLD's resilience compared to higher-leverage alternatives during market downturns, with institutional buying activity noted in recent filings.
The outlook remains cautiously optimistic given the bullish technical setup, though investors face volatility risks from Federal Reserve policy and Nasdaq concentration. QLD's 2x leverage strategy offers a middle ground for Nasdaq-100 exposure, but requires careful risk management during market stress periods.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Ultra QQQ ETF
QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
